CompletedNot Applicable

Physiotherapy Applications in Lateral Epicondylitis

Turkey (Türkiye)42 participantsStarted 2020-06-10

Plain-language summary

This study aims to compare the effectiveness of extracorporeal shock wave therapy (ESWT) and high-intensity laser therapy (HILT) in improving pain, grip strength, and function in patients with lateral epicondylitis. A total of 42 volunteer patients aged 18-65 were enrolled at Balıkesir Private Sevgi Hospital physical medicine polyclinic. Participants were randomly assigned into three groups: group 1 received conventional physiotherapy, group 2 received physiotherapy plus ESWT, and group 3 received physiotherapy plus HILT. Physiotherapy was applied for 2 weeks, totaling 10 sessions. ESWT and HILT were each administered twice weekly for 2 weeks, totaling 4 sessions. Pain was measured using the visual analog scale (VAS), grip strength with a hand dynamometer, and function using the Duruöz Hand Index and PRTEE-T questionnaire. Evaluations were performed before treatment, after 2 weeks, and one month post-treatment.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being over the age of 18, * Being diagnosed with lateral epicondylitis, * Not having received lateral epicondylitis treatment in the last 3 months Exclusion Criteria: * Stopping the treatment, * Those who have been traumatized in the last 3 months, * Those who use drugs that can affect muscle strength or pain level (muscle relaxants, analgesics, gabapentinoids, etc.) * Those with open wounds in the elbow area, Those with elbow fractures, Those with drug allergies, Pregnant and breastfeeding women.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Pain Severity - Visual Analog Scale (VAS)

Timeframe: Baseline (Day 1), at the end of 2-week treatment, 4 weeks after treatment completion

Grip Strength - Hand Dynamometer

Timeframe: Baseline (Day 1), at the end of 2-week treatment, 4 weeks after treatment completion

Upper Extremity Function - Duruöz Hand Index

Timeframe: Baseline (Day 1), at the end of 2-week treatment, 4 weeks after treatment completion

Functional Evaluation - PRTEE-T (Patient-Rated Tennis Elbow Evaluation)

Timeframe: Baseline (Day 1), at the end of 2-week treatment, 4 weeks after treatment completion

Trial details

NCT IDNCT07028840

SponsorPamukkale University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-09-05

View on ClinicalTrials.gov More Lateral Epicondylitis trials

Plain-language summary

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Pain Severity - Visual Analog Scale (VAS)

Timeframe: Baseline (Day 1), at the end of 2-week treatment, 4 weeks after treatment completion

Grip Strength - Hand Dynamometer

Timeframe: Baseline (Day 1), at the end of 2-week treatment, 4 weeks after treatment completion

Upper Extremity Function - Duruöz Hand Index

Timeframe: Baseline (Day 1), at the end of 2-week treatment, 4 weeks after treatment completion

Functional Evaluation - PRTEE-T (Patient-Rated Tennis Elbow Evaluation)

Timeframe: Baseline (Day 1), at the end of 2-week treatment, 4 weeks after treatment completion